Use of zoledronate for treatment of a bone fragility disorder in horses.

Objective: To assess clinical outcomes and scintigraphic findings in horses with a bone fragility disorder (BFD) treated with zoledronate (a nitrogen-containing bisphosphonate).

Design: Prospective uncontrolled clinical trial.

Animals: 10 horses with evidence of a BFD.

Radiography and computed tomography in the diagnosis of nonneoplastic equine mandibular disease.

We compared the information gained from computed tomography (CT) vs. radiography in horses with nonneoplastic disease of the mandible. We hypothesized that CT would provide additional diagnostic information.